Boric Acid Affects the Expression of DNA Double-Strand Break Repair Factors in A549 Cells and A549 Cancer Stem Cells: An In Vitro Study

Overview

Journal Biol Trace Elem Res

Date 2024 Feb 17

PMID 38367174

Authors

Tugba Semerci Sevimli

Aynaz Ghorbani

Bahar Demir Cevizlidere

Burcugul Altug

Murat Sevimli

Affiliations

Soon will be listed here.

Abstract

DNA double-strand break (DSB) repair genes interact with tumor stemness- and resistance-associated processes in cancer stem cells (CSCs). Therefore, targeting DNA DSB genes in cancer treatment is important for the CSC phenotype. Although the anti-cancer effect of boric acid (BA) has been studied, its effect on DNA DSB is unclear. Moreover, no studies investigate BA's effects on DNA DSB of lung cancer stem cells (LC-SCs). To fill the gap, we aimed to assess the effects of BA on A549 cancer stem cells. CSCs were isolated from human non-small cell lung cancer cells (A549) and characterized by flow cytometry. Different concentrations of BA (at doses ranging from 1 to 100 mM) were applied to cancer stem cells. Cytotoxic activities were determined using the cell viability assay (MTT assay) at 24 and 48 h. Expression levels of DNA DSB genes that BRCA1, BRCA2, RAD51, KU70/80, ATM, and XRCC4 were evaluated by RT-qPCR. Additionally, immunofluorescence staining analysis was exploited for caspase-3 and E-cadherin. ATM expression increased significantly (p < 0.001). No significant change was observed in the expression of other genes. Moreover, BA up-regulated caspase-3 and E-cadherin expression. Consequently, we can say that BA affects DNA DSB and the apoptotic abilities of LC-SCs.

References

Horeweg N, Scholten E, de Jong P, van der Aalst C, Weenink C, Lammers J . Detection of lung cancer through low-dose CT screening (NELSON): a prespecified analysis of screening test performance and interval cancers. Lancet Oncol. 2014; 15(12):1342-50. DOI: 10.1016/S1470-2045(14)70387-0. View

Zappa C, Mousa S . Non-small cell lung cancer: current treatment and future advances. Transl Lung Cancer Res. 2016; 5(3):288-300. PMC: 4931124. DOI: 10.21037/tlcr.2016.06.07. View

Corti A, Dominici S, Piaggi S, Pompella A . Enhancement of ferroptosis by boric acid and its potential use as chemosensitizer in anticancer chemotherapy. Biofactors. 2022; 49(2):405-414. DOI: 10.1002/biof.1919. View

Visvader J, Lindeman G . Cancer stem cells: current status and evolving complexities. Cell Stem Cell. 2012; 10(6):717-728. DOI: 10.1016/j.stem.2012.05.007. View

Yu Z, Pestell T, Lisanti M, Pestell R . Cancer stem cells. Int J Biochem Cell Biol. 2012; 44(12):2144-51. PMC: 3496019. DOI: 10.1016/j.biocel.2012.08.022. View

Morrison B, Morris J, Steel J . Lung cancer-initiating cells: a novel target for cancer therapy. Target Oncol. 2013; 8(3):159-172. PMC: 3763165. DOI: 10.1007/s11523-012-0247-4. View

Paties Montagner G, Dominici S, Piaggi S, Pompella A, Corti A . Redox Mechanisms Underlying the Cytostatic Effects of Boric Acid on Cancer Cells-An Issue Still Open. Antioxidants (Basel). 2023; 12(6). PMC: 10294879. DOI: 10.3390/antiox12061302. View

Semerci Sevimli T, Ghorbani A, Gakhiyeva F, Cevizlidere B, Sevimli M . Boric Acid Alters the Expression of DNA Double Break Repair Genes in MCF-7-Derived Breast Cancer Stem Cells. Biol Trace Elem Res. 2023; 202(9):3980-3987. DOI: 10.1007/s12011-023-03987-4. View

Prabavathy D, Swarnalatha Y, Ramadoss N . Lung cancer stem cells-origin, characteristics and therapy. Stem Cell Investig. 2018; 5:6. PMC: 5897668. DOI: 10.21037/sci.2018.02.01. View

Kumar V, Vashishta M, Kong L, Wu X, Lu J, Guha C . The Role of Notch, Hedgehog, and Wnt Signaling Pathways in the Resistance of Tumors to Anticancer Therapies. Front Cell Dev Biol. 2021; 9:650772. PMC: 8100510. DOI: 10.3389/fcell.2021.650772. View

Zhu Q, Shen Y, Chen X, He J, Liu J, Zu X . Self-Renewal Signalling Pathway Inhibitors: Perspectives on Therapeutic Approaches for Cancer Stem Cells. Onco Targets Ther. 2020; 13:525-540. PMC: 6970631. DOI: 10.2147/OTT.S224465. View

Yang L, Shi P, Zhao G, Xu J, Peng W, Zhang J . Targeting cancer stem cell pathways for cancer therapy. Signal Transduct Target Ther. 2020; 5(1):8. PMC: 7005297. DOI: 10.1038/s41392-020-0110-5. View

Nooreldeen R, Bach H . Current and Future Development in Lung Cancer Diagnosis. Int J Mol Sci. 2021; 22(16). PMC: 8395394. DOI: 10.3390/ijms22168661. View

10.

Rezayatmand H, Razmkhah M, Razeghian-Jahromi I . Drug resistance in cancer therapy: the Pandora's Box of cancer stem cells. Stem Cell Res Ther. 2022; 13(1):181. PMC: 9066908. DOI: 10.1186/s13287-022-02856-6. View

11.

Cabus U, Secme M, Kabukcu C, Cil N, Dodurga Y, Mete G . Boric acid as a promising agent in the treatment of ovarian cancer: Molecular mechanisms. Gene. 2021; 796-797:145799. DOI: 10.1016/j.gene.2021.145799. View

12.

Cebeci E, Yuksel B, Sahin F . Anti-cancer effect of boron derivatives on small-cell lung cancer. J Trace Elem Med Biol. 2022; 70:126923. DOI: 10.1016/j.jtemb.2022.126923. View

12.

Romeo H, Arcos M . Clinical relevance of stem cells in lung cancer. World J Stem Cells. 2023; 15(6):576-588. PMC: 10324501. DOI: 10.4252/wjsc.v15.i6.576. View

13.

Yilmaz S, Ustundag A, Ulker O, Duydu Y . Protective Effect of Boric Acid on Oxidative DNA Damage In Chinese Hamster Lung Fibroblast V79 Cell Lines. Cell J. 2016; 17(4):748-54. PMC: 4746425. DOI: 10.22074/cellj.2016.3847. View

14.

Barranco W, Eckhert C . Boric acid inhibits human prostate cancer cell proliferation. Cancer Lett. 2004; 216(1):21-9. DOI: 10.1016/j.canlet.2004.06.001. View

15.

Sevimli M, Bayram D, Ozgocmen M, Armagan I, Semerci Sevimli T . Boric acid suppresses cell proliferation by TNF signaling pathway mediated apoptosis in SW-480 human colon cancer line. J Trace Elem Med Biol. 2022; 71:126958. DOI: 10.1016/j.jtemb.2022.126958. View